Month: May 2022

Not for distribution to United States Newswire Services or for dissemination in the United States TORONTO, May 31, 2022 (GLOBE NEWSWIRE) — Bunker Hill Mining Corp. (the “Company”) (CSE: BNKR; OTCQB: BHLL) is pleased to announce that the Company received a receipt today from the Ontario Securities Commission for its final short-form Canadian prospectus (the “Prospectus”) qualifying the distribution of the common stock of the Company (“Common Shares”) and common stock purchase warrants of the Company (“Warrants”) issuable upon exercise of the special warrants of the Company (“Special Warrants”) that were issued on April 1, 2022. The Company is also pleased to announce that it received notice from the United States Securities and Exchange Commission that its Form S-1 has...

TORONTO, May 31, 2022 (GLOBE NEWSWIRE) — Dundee Corporation (TSX: DC.A) (the “Corporation” or “Dundee”) today announces that TauRx Pharmaceuticals Ltd. (“TauRx”), a leader in tau-based research in Alzheimer’s, unveiled initial data from the randomised portion of their widely followed Phase 3 clinical trial, LUCIDITY (NCT03446001). Dundee holds 1,015,008 shares in TauRx. For a copy of TauRx’s official announcement, please visit: https://ts-assets.ams3.cdn.digitaloceanspaces.com/mg/tx/pdfs/Lucidity-Data-Announcement.31May2022.for-website.pdf TauRx Announcement Highlights:LUCIDITY data suggest that participants receiving hydromethylthionine mesylate (“HMTM”) decline at a rate substantially less than is typical in Alzheimer’s based on published research.Safety profile is favourable and consistent with previous HMTM studies.TauRx...

NEW YORK, May 31, 2022 (GLOBE NEWSWIRE) — 1stdibs.com, Inc. (Nasdaq: DIBS), a leading online marketplace for luxury design products, announced today that CEO David Rosenblatt and CFO Tom Etergino will present at the William Blair 42nd Annual Growth Stock Conference on Monday, June 6th at 1:40pm ET. A live webcast and replay of these sessions will be featured on the company’s Investor Relations website (investors.1stdibs.com). About 1stDibs1stDibs is a leading online marketplace for connecting design lovers with highly coveted sellers and makers of vintage, antique, and contemporary furniture, home décor, art, jewelry, watches and fashion. Investor Relations Contact:Kevin LaBuz, Head of Investor Relationsinvestors@1stDibs.com Media Contact:Jennifer Millerjennifer.miller@1stdibs.com

VANCOUVER, British Columbia, May 31, 2022 (GLOBE NEWSWIRE) — Trailbreaker Resources Ltd. (TBK.V) (“Trailbreaker” or “the Company”) announces that subject to all regulatory approvals, the Company has granted 785,000 incentive stock options to directors, officers, and certain consultants of the Company. All Options issued pursuant to this grant shall vest immediately, have a term of 5 years and are exercisable at $0.24. ON BEHALF OF THE BOARD Daithi Mac GearailtPresident and Chief Executive Officer For new information about the Company’s projects, please visit Trailbreaker’s website at TrailbreakerResources.com and sign up to receive news. For further information, follow Trailbreaker’s tweets at Twitter.com/TrailbreakerLtd, use the ‘Contact’ section of our website, or contact us at (604) 681-1820 or at info@trailbreakerresources.com. Neither...

CHICAGO and TORONTO, May 31, 2022 (GLOBE NEWSWIRE) — Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care paradigms today, has today announced its first quarter 2022 financial results. Q1 2022 HighlightsDelivered findings indicating psilocybin potentiates impact of anti-depressant Received positive feedback from pre-Investigational New Drug (“IND”) meeting with U.S. Food and Drug Administration (“FDA”) on SANA-013 Announced positive findings from Animal Study on Novel Depression Treatment Protocol Combining Psilocybin and Cannabidiol Record Q1 2022 operating results at Wesana Clinics Opening of third Wesana Clinic in May 2022 Launched strategic Review of Care Delivery AssetsSelect Consolidated...

JV Secures $226 Million Construction Loan from Wells Fargo N.A., BNY Mellon, and The Bank of East Asia, Limited, New York BranchLyra Boston, MAFORT WASHINGTON, Pa., May 31, 2022 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE: TOL) (TollBrothers.com), the nation’s leading builder of luxury homes, through its Toll Brothers Apartment Living® rental division, and PGIM Real Estate, the real estate investment and financing business of PGIM, the $1.5 trillion global asset management business of Prudential Financial (NYSE: PRU) have announced another new joint venture to develop Lyra, a 34-story, 432-unit multifamily rental community in downtown Boston, MA. The project, which will be the first development by Toll Brothers Apartment Living (TBAL) in Boston, is being financed through a $226 million construction loan facility from Wells...

EDISON, N.J., May 31, 2022 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”) and hepatocellular carcinoma (“HCC”), today urged its stockholders to vote “FOR” all proposals put forth in the definitive proxy statement prior to its June 24, 2022 Annual Meeting of Stockholders. “As one equity analyst recently observed in a research note, our industry is facing one of the worst biotech tapes in a generation,” said Dr. Robert Foster, PharmD, PhD, Hepion’s CEO. “Indeed, since the market peaked in February 2021, the aggregate enterprise value of the world’s biotech sector is down approximately 50%, and over one-half of individual biotech sector...